DYN Operating Cash Flow (Statement)
Dyne Therapeutics Inc · Operating Cash Flow (Statement)
DYN Operating Cash Flow (Statement)
Latest reported-$130.29Mperiod ending
DYN Quarterly Cash from Operations ($113.00M → -$130.29M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
DYN operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -130,286,000 | |
| -144,922,000 | |
| -111,832,000 | |
| -90,779,000 | |
| -94,703,000 | |
| -105,893,000 | |
| -84,335,000 | |
| -74,629,000 | |
| -54,868,000 | |
| -78,537,000 | |
| -35,006,000 | |
| -50,602,000 | |
| -55,642,000 | |
| -46,908,000 | |
| -29,192,000 | |
| -42,805,000 | |
| -30,909,000 | |
| -50,739,000 | |
| -28,068,000 | |
| -26,952,000 | |
| -46,150,000 | |
| -18,393,000 | |
| -20,036,000 | |
| -11,873,000 | |
| -7,311,000 | |
| -7,288,000 | |
| -4,014,000 | |
| -2,976,000 | |
| -2,422,000 | |
| -2,422,000 | |
| 84,000,000 | |
| 271,000,000 | |
| 81,000,000 | |
| 149,000,000 | |
| 27,000,000 | |
| 332,000,000 | |
| 126,000,000 | |
| 191,000,000 | |
| -208,000,000 | |
| 323,000,000 | |
| 34,000,000 | |
| -55,000,000 | |
| -338,000,000 | |
| 113,000,000 | |
| -3,000,000 | |
| 166,000,000 | |
| 43,000,000 | |
| 142,000,000 | |
| -3,000,000 | |
| -7,000,000 | |
| 37,000,000 | |
| 61,000,000 | |
| -78,000,000 | |
| -20,000,000 | |
| -70,000,000 | |
| 136,000,000 | |
| -169,000,000 | |
| 83,000,000 | |
| -247,000,000 | |
| 302,000,000 | |
| 365,083,761 | |
| 458,000,000 | |
| -169,000,000 | |
| 244,000,000 | |
| -105,000,000 | |
| 165,000,000 | |
| -78,000,000 | |
| 365,000,000 | |
| -114,000,000 | |
| 146,000,000 | |
| -25,000,000 | |
| 209,000,000 | |
| 113,000,000 |